Legend Biotech (LEGN) Appoints Ying Huang to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Legend Biotech Announces Appointment of Dr. Ying Huang to the Board of Directors
December 30, 2021 8:30 AM ESTSOMERSET, N.J.--(BUSINESS WIRE)-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, announced today that Dr. Ying Huang, Legend Biotechs Chief Executive Officer and Chief Financial Officer, has been appointed as a director to Legend Biotechs Board of Directors. Dr. Huang will serve as a Class I director.
We are delighted to have Dr. Huang join our Board of Directors, said Sally Wang, Chairwoman of Legend Biotech. As Legend Biotechs Chief Executive Officer and Chief Financial Officer, Dr. Huang has been... More
